Egalet (STU:EGP) Other Current Receivables: €0.79 Mil (As of Mar. 2020)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Egalet Other Current Receivables?

Egalet STU:EGP Other Current Receivables is €0.79 Mil as of Mar. 2020. The stock has 2 warning signs investors should review.

Egalet's Other Current Receivables for the quarter that ended in Mar. 2020 was €0.79 Mil.

Egalet's quarterly Other Current Receivables increased from Sep. 2019 (€0.00 Mil) to Dec. 2019 (€0.73 Mil) and increased from Dec. 2019 (€0.73 Mil) to Mar. 2020 (€0.79 Mil).

Egalet's annual Other Current Receivables declined from Dec. 2017 (€0.76 Mil) to Dec. 2018 (€0.74 Mil) and declined from Dec. 2018 (€0.74 Mil) to Dec. 2019 (€0.73 Mil).

Egalet Other Current Receivables Related Terms

Egalet Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Egalet's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Egalet Other Current Receivables Chart

Egalet Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only 1.01 0.95 0.76 0.74 0.73

Egalet Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.14 0.00 0.73 0.79

Egalet Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €0.79 Mil mean?
Egalet (STU:EGP) has a Other Current Receivables of €0.79 Mil as of Mar. 2020. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Egalet and its competitors.
Is Egalet's Other Current Receivables too high?
Egalet's current Other Current Receivables is €0.79 Mil.
How does Egalet's Other Current Receivables compare to CPHI and TLGT?
Egalet's Other Current Receivables of €0.79 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Egalet and its competitors. Egalet's current Other Current Receivables is €0.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Egalet stock overvalued right now?
Egalet (STU:EGP) has a current Other Current Receivables of €0.79 Mil. The current Other Current Receivables is €0.79 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Egalet (STU:EGP), the current Other Current Receivables is €0.79 Mil as of Mar. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Egalet Business Description

Address 600 Lee Road, Suite 100, Wayne, PA, USA, 19087
Zyla Life Sciences is a U.S based company focused on marketing its portfolio of medicines for pain and inflammation. The products offered by the company include Sprix, Oxaydo, Vivlodex, Zorvolex, Tivorbex and Indocin Oral Suspension among others.